ReviewClinical Medicine Insights. Oncology2021

Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects.

Tianhang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.